Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics (Q37427107)
Jump to navigation
Jump to search
scientific article published on 05 January 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics |
scientific article published on 05 January 2016 |
Statements
1 reference
Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics (English)
1 reference
Alessandra Ferrajoli
1 reference
Stefan Faderl
1 reference
William G Wierda
1 reference
Susan O'Brien
1 reference
George Calin
1 reference
Michael J Keating
1 reference
Lorenzo Falchi
1 reference
Candida Vitale
1 reference
Jan A Burger
1 reference
Elisa Ten Hacken
1 reference
Hila Shaim
1 reference
Katayoun Rezvani
1 reference
Hui Gao
1 reference
Katrien Van Roosbroeck
1 reference
Xuemei Wang
1 reference
James M Reuben
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference